Neuphoria Therapeutics (NEUP) Q2 2025 Earnings

20MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-2.01
-1.5
-0.98
-0.47

Details

Expected EPS
-1.26
Actual EPS
-1.26
Surprise EPS
0
Surprise Percent
+0%

Description

Neuphoria Therapeutics (NEUP) has reported earnings of -1.26 per share for Q2 2025.

0 Comments

Share your thoughts